Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare ConferenceGlobeNewsWire • 05/13/26
Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel's Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026GlobeNewsWire • 05/12/26
Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Beats Revenue EstimatesZacks Investment Research • 05/07/26
Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business UpdatesGlobeNewsWire • 05/07/26
Beam Therapeutics' CEO Sold Over 30,000 Company Shares. Here's What This Means for Investors.The Motley Fool • 04/11/26
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of MedicineGlobeNewsWire • 04/01/26
Beam Therapeutics Inc. (BEAM) Discusses Topline Phase I/II Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency TranscriptSeeking Alpha • 03/26/26
Beam Therapeutics Gains On Clinical Update As Gene Therapy Hits Protective Protein LevelsBenzinga • 03/25/26
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal DevelopmentGlobeNewsWire • 03/25/26
Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?Zacks Investment Research • 03/12/26
Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Beats Revenue EstimatesZacks Investment Research • 02/24/26
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)GlobeNewsWire • 02/24/26
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth StreetGlobeNewsWire • 02/24/26
Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease ProgramGlobeNewsWire • 02/23/26
Beam Therapeutics Inc. (BEAM) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
BEAM Outlines Key Strategic & Pipeline Goals for 2026, Stock RisesZacks Investment Research • 01/13/26